Dr. Ruka Canada
              
                Introduction to the
CMVS Programs (Brief Overview)

                                                                                              
Total Number of Words Published (TWP): 746

The Cambridge Center for Medical & Veterinary Sciences Inc. (CMVS), is raising a start-up capital / investment for
PHASE ONE and PHASE 2 (click here to access a 32-slide presentation) in the amount of USD16.5 million to
construct a 280,000 sq. ft. teaching-learning Companion Small Animal General
Hospital in Greater Toronto Area
(GTA - York / Durham Region), as the first and only such facility in North America to carry out clinical kidney
transplantation, a life-saving procedure, into dog recipients diagnosed with the end-stage of organ disease.

In view of shortage of organs donors, the efforts of establishing sources of organs in sufficient numbers from e.g. the
animal donor (pig), increase in the number of small animal patients diagnosed with uremia or diabetes and the pet
owners increased demand for the treatment of these diseases by organ transplantation, the increased interest of medical,
veterinary, and biological professionals and the public in the medical, social, and ethical issues of using animal(s) for
medical research,
The Cambridge Center for Medical & Veterinary Sciences Inc. (CMVS) will implement its mission
statement and goals in the form of establishing clinical, teaching, (applied) research and diagnostic programs in the field
of organ transplantation (but not limited to), for the benefit of humans and animals health.

These programs are going to be implemented by establishing an (1) international co-operation with selected
medical/veterinary scientific/transplant center(s) in e.g. the U.S.A. (Boston, New York City, California), Europe
(Holland, England), Japan (Tokyo) or New Zealand (Auckland), and by (2) developing and establishing the
Hospital
with its distinct and accredited / certified facilities in the form of:
PHASE I - (a) Companion Small Animal General Hospital [CAH, a referral 280,000-square-foot Hospital with its
in-patients and out-patients regular and routine daily clinical work is planned to be constructed in Greater Toronto
Area (GTA, Ontario, Canada) following the human hospital standards
] is referred in the CMVS materials as the
Hospital-CAH;
NOTE: According to the
CMVS Business Plan, in the initial stage of PHASE ONE of this project (immediately after
receiving an investment), the
CMVS office (its Headquarters) will be established in Greater Toronto Area (GTA,
Ontario, Canada), and its current office temporally located in the City of Guelph (Ontario, Canada) will move out to its
new location.
PHASE II - (b) Research Wing (to-be constructed as a 75,000-square-foot facility, and licensed by the CCAC, CVO,
etc.
) for embryo lab, immuno-genetic lab, etc., and
PHASE III - (c) Wing / Department of Auto-/Allo-/ Xeno- organ/tissue/stem cells/genome transplantation into Human
Recipients.

The official name and plan of these facilities (including the
Hospital-CAH) are still in the process of being established
(and pending on investment), in accordance with all applicable Local (Institutional), Municipal, Provincial, and Federal
regulations and guidelines including the College of Veterinarians of Ontario (CVO), Canadian Council on Animal Care
(CCAC), Animal for Research Act (ARA), Ministry of Health, Ministry of Sciences, Ministry of Education and
Training, Ministry of Agriculture Food & Rural Affairs, and other relevant Canadian institutions.

This the first efforts, in the history of human and veterinary transplant medicine, of bringing a group of veterinary
clinical uremic and diabetic dogs and cats patients as a new clinical model in the treatment of naturally occurring
diseases such as uremia and diabetes by organ transplantation, conditions affecting approximately 1.5% of 150 million
dogs and cats living in the USA and Canada. The knowledge gained and results obtained from the treatment, established
techniques, approved-established protocols and projects will be immediately applied, initially in the form of
pre-clinical trials, into human transplant recipients.


ADDITIONAL NOTES to the Potential Investor or any Individual(s) who is (are) interested in our programs:

In case that you need more information about the
CMVS programs, please do not hesitate to contact our Office
(temporally located in Guelph, Ontario, Canada) to require a full copy of the
CMVS Executive Summary, which will be
sent to you (by e-mail as an attachment, or by express-post) as soon as possible.

Please note that, additionally, after signing the
CMVS Confidentiality Agreement, there will be a possibility of receiving
from us the
Handbook For The CMVS' Programs Investor (total 80 pages divided into 10 Chapters, containing all
essential information including the
CMVS' Business Plan) giving a condense overview of the CMVS programs to be
established in Central Ontario (Greater Toronto Area), Canada.

Please, do not hesitate to contact our
Office for further information.

CMVS is Open for an Equity Investment (% of Ownership)

                                                              Total Number of Words Published: 72

   Currently, the CMVS, is in the process of searching for, from the
 private sector (private investor), an investment in the amount of USD16.5
 million to generate a return on interest of the protected investment (made
 into the
CMVS) of approximately USD1.6 million per year, under condition
 that the Bank's interest rate on long-term investments is 10%.
The CMVS is a clinical, teaching, research with diagnostic labs and services CENTER established to
assess the strategies to be undertaken by professionals in their fields of expertise (veterinary, human
medicine, biology, etc.) in organ/tissue/stem cells transplantation/regeneration, oncolocgy, and genome
for the public health - the benefit of humans and animals
Dr. Ruka
Copyright 2016 © The Cambridge Center for Medical & Veterinary Sciences Inc. (CCMVS). All rights reserved.
TM
The Cambridge Center
for Medical & Veterinary
Sciences Inc. (CMVS)
Click here to...